By Linda on Aug 16, 2010 in Infections | comments(0)
More proof that autoimmune disease patients have chronic infections that are not widely recognized; this time we are talking about TB!
This research further supports the need for serious efforts to lower the total body burden of pathogens in all autoimmune diseases since 19% tested positive to TB. Of course they may all well have other concurrent infections with things like Chlamydia and CMV and even LYME too. No one has the dollars to fully test for every possible infection, and thus affordable non-toxic, out-patient, anti-infective therapies like ACS take a tremendous importance. It is always nice if initially some IV UVB and Ozone can be given to really aggressively lower the burden but always know that long term use of ACS and related
infection control nutrients are crucial, as the organism are usually never completely eradicated, and when they return, exacerbations of the autoimmune condition will follow.
This is the conclusion from this research - 19% test positive for TB.
Overall, 74 (19%) out of 393 subjects were TST-positive and 52 (13%) were QFT-GIT-positive. Concordance between TST and QFT-GIT results was good (87.7%): 13 were QFT-GIT-positive/TST-negative and 35 QFT-GIT-negative/TST-positive.
Garry F. Gordon MD,DO,MD(H)
President, Gordon Research Institute
www.gordonresearch.com
Full article: http://erj.ersjournals.com/cgi/content/abstract/33/3/586
Excerpt:
Screening for active tuberculosis (TB) and latent TB infection (LTBI) is mandatory prior to the initiation of tumour necrosis factor- inhibitor therapy. However, no agreement exists on the best strategy for detecting LTBI in this population. The aim of the present study was to analyse the performance of the tuberculin skin test (TST) and QuantiFERON®-TB Gold in-tube (QFT-GIT) on LTBI detection in subjects with immunomediated inflammatory diseases (IMID).
The TST and QFT-GIT were prospectively performed in 398 consecutive IMID subjects, 310 (78%) on immunosuppressive therapy and only 16 (4%) had been bacillus Calmette–Guérin (BCG) vaccinated.
Indeterminate results to QFT-GIT were found in five (1.2%) subjects. Overall, 74 (19%) out of 393 subjects were TST-positive and 52 (13%) were QFT-GIT-positive. Concordance between TST and QFT-GIT results was good (87.7%): 13 were QFT-GIT-positive/TST-negative and 35 QFT-GIT-negative/TST-positive. By multivariate analysis both tests were significantly associated with older age. Only the TST was associated with BCG vaccination and radiological lesions of past TB. Use of immunosuppressive drugs differently modulated QFT-GIT or TST scoring.
By Linda on Jun 17, 2010 in F.I.G.H.T. | comments(0)
Are you sick and tired? My FIGHT4YOURHEALTH program can change your life even if you think LYME is your only problem. Learn more and become vibrantly healthy again.
Garry F. Gordon MD,DO,MD(H)
President, Gordon Research Institute
www.gordonresearch.com
Full article: http://bolenreport.com/feature_articles/feature_article072.htm
Excerpt:
Most people battling chronic Lyme disease think of the illness as an infection caused by a bacterium known commonly as Borrelia Burgdorferi, generally transmitted via the bite of an infected tick. What many don’t recognize, however, is that recovery from chronic Lyme disease requires a recognition that the disease is truly a much more complex illness. Recovery often challenges one to consider more than just infection as the single causative agent involved in the disease process. It is through looking beyond the infectious component of Lyme disease and understanding the equally important aspects of damaging heavy metals and other toxic insults that a more full and lasting recovery may be realized.
Garry F. Gordon MD, DO, MD (H) co-founded the American College for Advancement in Medicine (ACAM) and serves as the President of Gordon Research Institute. Dr. Gordon graciously spent a couple of hours with me sharing his views on chronic Lyme disease and those factors that are important in recovering from chronic illness.
Dr. Gordon acknowledges Lyme disease as a serious infection which can lead to a wide-variety of health challenges. He does not, however, hyperfocus on the specific tick-borne pathogens which cause the disease. He instead believes that a multitude of infections are prevalent in anyone with chronic ill health. In addition to these numerous infections, our state of health is closely tied to our total body burden of endogenous and exogenous toxins. When looking at why illness is present, it is important to look at a number of factors including genetics, chronic infections, and total body burden of heavy metals and other toxins.
Peering into one’s genetic makeup can be quite helpful when establishing the proper course of action and considering what factors may have contributed to one’s state of health. The more precisely a practitioner can understand the genetic contributors, the more accurately a treatment protocol can be outlined to fit a person’s unique needs. As an example, a specific gene mutation can suggest an inability of the body to remove toxic heavy metals. Thus, even tests performed to determine whether or not one is heavy metal toxic can be incorrect if the metals are not being released due to this specific genetic profile. Where many doctors may miss a heavy metal toxicity issue in these patients, a practitioner incorporating a genetic review into their diagnostic workup is much better equipped to evaluate the potential impact of toxic metals on the overall state of health.
By Linda on Nov 26, 2009 in Infections | comments(2)
Linda’s comment: Several of us have been trying for years to get the Department of Health to classify Lyme disease as an STD. Doctors including Lyme Literate Medical Doctors=LLMD’s, are split. We now know that Lyme can be sexually transmitted. It makes sense to classify Lyme as STD. We need to do all we can to help stop the spread of Lyme and Company. I suggest when talking to your children about their sexual activities, to strongly warn them about the chance of getting sexually transmitted Lyme. Continued
By Linda on Nov 23, 2009 in Infections | comments(0)
Spondylarthritis (SpA) represents a group of arthritidies that share clinical features such as inflammatory back pain and inflammation at sites where tendons attach to bone. It includes ankylosing spondylitis (AS), psoriatic arthritis, inflammatory bowel-disease-related arthritis, reactive arthritis (ReA) and undifferentiated spondylarthritides (uSpA). Since Chlamydia trachomatis or Chlamydia pneumoniae (which are often asymptomatic) frequently cause ReA, a new study examined whether there was a connection between these two infections and uSpA. Continued
